TOM70 in Glial Cells as a Potential Target for Treatment of COVID-19
Main Authors: | Yorran Hardman Araújo Montenegro, Geancarlo Zanatta, André Quincozes-Santos, Guilhian Leipnitz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fncel.2021.811376/full |
Similar Items
-
Why antidiabetic drugs are potentially neuroprotective during the Sars-CoV-2 pandemic: The focus on astroglial UPR and calcium-binding proteins
by: Carlos-Alberto Gonçalves, et al.
Published: (2022-07-01) -
Tom70-based transcriptional regulation of mitochondrial biogenesis and aging
by: Qingqing Liu, et al.
Published: (2022-03-01) -
Nuclear Factor Erythroid-2-Related Factor 2 Signaling in the Neuropathophysiology of Inherited Metabolic Disorders
by: Bianca Seminotti, et al.
Published: (2021-11-01) -
TOM complex‐independent transport pathway of myoglobin into mitochondria in C2C12 myotubes
by: Rikuhide Koma, et al.
Published: (2023-04-01) -
The selectivity filter of the mitochondrial protein import machinery
by: Sebastian Kreimendahl, et al.
Published: (2020-10-01)